Home > Income Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Consolidated Net Profit

    Back to Income Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹3,486 Cr₹3,173 Cr₹1,928 Cr₹2,648 Cr₹5,335 Cr

What is the latest Consolidated Net Profit of AUROBINDO PHARMA ?

The latest Consolidated Net Profit ratio of AUROBINDO PHARMA is ₹3,486 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹3,486 Cr
Mar2024₹3,173 Cr
Mar2023₹1,928 Cr
Mar2022₹2,648 Cr
Mar2021₹5,335 Cr

How is Consolidated Net Profit of AUROBINDO PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹3,486 Cr
9.86
Mar2024 ₹3,173 Cr
64.62
Mar2023 ₹1,928 Cr
-27.21
Mar2022 ₹2,648 Cr
-50.36
Mar2021 ₹5,335 Cr -

Compare Consolidated Net Profit of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹65,813.4 Cr -2.9% -6.9% -4.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,488.0 Cr -2.5% -7% -8% Stock Analytics
DIVIS LABORATORIES ₹159,415.0 Cr -2.2% -7.2% 1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹132,906.0 Cr -4% 2.8% 27.1% Stock Analytics
CIPLA ₹106,210.0 Cr -5.5% -12.4% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,089.0 Cr 5.9% -3.7% -6.5% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-2.9%

-6.9%

-4.8%

SENSEX

-2.4%

-4.7%

6.4%


You may also like the below Video Courses